Biblio Discovery — Demo Discovery Service

14 results for "Pierre Gobin"

Showing 1–14 · 1.06 seconds · RSS

  1. Journal Article Full text

    Anatomic measurements of cerebral venous sinuses in idiopathic intracranial hypertension patients

    Srikanth R. Boddu; Pierre Gobin; Cristiano Oliveira et al.

    PLOS ONE, Vol. 13 No. 6 · 2018 · English · PLOS Scopus

    Purpose: Magnetic resonance venography (MRV) has not been validated in pre-operative planning of the dural venous sinus stenting (VSS) among idiopathic intracranial hypertension (IIH) patients. We aim to prospectively evaluate dural venous sinus measurement in IIH patient population on…

  2. Journal Article Full text

    Ten-year experience with ophthalmic artery chemosurgery: Ocular and recurrence-free survival

    Jasmine H. Francis; Ariana M. Levin; Emily C. Zabor et al.

    PLOS ONE, Vol. 13 No. 5 · 2018 · English · PLOS Scopus

    Purpose: To report associations between disease- and treatment-related variables and rates of recurrence-free survival and ocular survival in eyes treated with ophthalmic artery chemosurgery (OAC) for retinoblastoma. Design: Pre-post study. Subjects: All eyes treated with OAC for retinoblastoma at…

  3. Journal Article Full text

    Ophthalmic Artery Chemosurgery for Less Advanced Intraocular Retinoblastoma: Five Year Review

    David H. Abramson; Brian P. Marr; Scott E. Brodie et al.

    PLoS ONE, Vol. 7 No. 4 · 2012 · English · PLOS Scopus

    Background: Ophthalmic artery chemosurgery (OAC) for retinoblastoma was introduced by us 5 years ago for advanced intraocular retinoblastoma. Because the success was higher than with existing alternatives and systemic side effects limited we have now treated less advanced intraocular retinoblastoma…

  4. Journal Article Full text

    Association of electroretinography with visual outcomes after ophthalmic artery chemosurgery for retinoblastoma in ICRb D and E eyes

    Ariana M. Levin; Jasmine H. Francis; Molly McFadden et al.

    PLOS ONE, Vol. 14 No. 1 · 2019 · English · PLOS Scopus

    Importance: Predictions of visual outcomes are useful in clinical and family decisions regarding treatment for retinoblastoma. Very little has been published on the association of post-treatment visual acuity with pre-treatment electroretinography (ERG), which can be performed on infants too young…

  5. Journal Article Full text

    Topotecan Delivery to the Optic Nerve after Ophthalmic Artery Chemosurgery

    Paula Taich; Flavio Requejo; Marcelo Asprea et al.

    PLOS ONE, Vol. 11 No. 3 · 2016 · English · PLOS Scopus

    Extraocular retinoblastoma is a major challenge worldwide, especially in developing countries. Current treatment involves the administration of systemic chemotherapy combined with radiation, but there is a clear need for improvement of chemotherapy bioavailability in the optic nerve. Our aim was to…

  6. Journal Article Full text

    Combined, Sequential Intravenous and Intra-Arterial Chemotherapy (Bridge Chemotherapy) for Young Infants with Retinoblastoma

    Y. Pierre Gobin; Ira J. Dunkel; Brian P. Marr et al.

    Public Library of Science · 2012 · English · PLOS Scopus

    Background: Intra-arterial (IA) chemotherapy has more risks of procedural complications in neonates and young infants. For these reasons, we have developed a strategy of bridge intravenous single agent chemotherapy to postpone IA chemotherapy in these children Procedure: Neonates and young infants…

  7. Journal Article Full text

    Risk Factors for Severe Neutropenia following Intra-Arterial Chemotherapy for Intra-Ocular Retinoblastoma

    Ira J. Dunkel; Weiji Shi; Kim Salvaggio et al.

    PLoS ONE, Vol. 9 No. 10 · 2014 · English · PLOS Scopus

    Purpose: Intra-arterial chemotherapy is a promising strategy for intra-ocular retinoblastoma. Neutropenia is the most commonly encountered systemic toxicity and in this study we aimed to determine the risk factors associated with the development of severe (≥grade 3) neutropenia. Methods…

  8. Journal Article Full text

    Carboplatin +/− Topotecan Ophthalmic Artery Chemosurgery for Intraocular Retinoblastoma

    Jasmine H. Francis; Y. Pierre Gobin; Ira J. Dunkel et al.

    PLoS ONE, Vol. 8 No. 8 · 2013 · English · PLOS Scopus

    Purpose: Carboplatin administered systemically or periocularly can result in dramatic and prompt regression of retinoblastoma. However, both routes are rarely curative alone and have undesirable side effects. We aimed to assess the efficacy and toxicity of carboplatin +/− topotecan delivered by…

  9. Journal Article Full text

    Electroretinogram Monitoring of Dose-Dependent Toxicity after Ophthalmic Artery Chemosurgery in Retinoblastoma Eyes: Six Year Review

    Jasmine H. Francis; David H. Abramson; Y. Pierre Gobin et al.

    PLoS ONE, Vol. 9 No. 1 · 2014 · English · PLOS Scopus

    Purpose: To report electroretinogram responses of retinoblastoma children under anesthesia before and after treatment with chemotherapeutic drugs (melphalan, topotecan, carboplatin) delivery by ophthalmic artery chemosurgery (OAC). Methods: A cohort study of 81 patients with retinoblastoma treated…

  10. Journal Article Full text

    Advanced Unilateral Retinoblastoma: The Impact of Ophthalmic Artery Chemosurgery on Enucleation Rate and Patient Survival at MSKCC

    David H. Abramson; Armida W. M. Fabius; Reda Issa et al.

    PLOS ONE, Vol. 10 No. 12 · 2015 · English · PLOS Scopus

    Purpose: To report on the influence of ophthalmic artery chemosurgery (OAC) on enucleation rates, ocular and patient survival from metastasis and impact on practice patterns at Memorial Sloan Kettering for children with advanced intraocular unilateral retinoblastoma. Patients and Methods…

  11. Journal Article Full text

    Intra-Arterial Chemotherapy (Ophthalmic Artery Chemosurgery) for Group D Retinoblastoma

    David H. Abramson; Anthony B. Daniels; Brian P. Marr et al.

    PLOS ONE, Vol. 11 No. 1 · 2016 · English · PLOS Scopus

    Purpose: To report globe salvage rates, patient survival and adverse events of ophthalmic artery chemosurgery (OAC) for International Classification of Retinoblastoma (ICRB) group D retinoblastoma (naive and after prior failures). Methods: Single institution retrospective review of all Group D eyes…

  12. Journal Article Full text

    Growth patterns of survivors of retinoblastoma treated with ophthalmic artery chemosurgery

    Sruti S. Akella; Jasmine H. Francis; Andrea Knezevic et al.

    PLOS ONE, Vol. 13 No. 5 · 2018 · English · PLOS Scopus

    Although studies from pediatric cancers (largely acute lymphoblastic leukemia) have shown that patients undergoing systemic chemotherapy may experience decreased growth velocity during the treatment phase, no such data exist for retinoblastoma patients treated with systemic chemotherapy or…

  13. Journal Article Full text

    Simultaneous Bilateral Ophthalmic Artery Chemosurgery for Bilateral Retinoblastoma (Tandem Therapy)

    David H. Abramson; Brian P. Marr; Jasmine H. Francis et al.

    PLOS ONE, Vol. 11 No. 6 · 2016 · English · PLOS Scopus

    Objective: Report on the 7-year experience with bilateral ophthalmic artery chemosurgery (OAC-Tandem therapy) for bilateral retinoblastoma. Design: Retrospective, single institution study. Subjects: 120 eyes of 60 children with bilateral retinoblastoma treated since March 2008. Methods…

  14. Journal Article Full text

    Total retinal detachments due to retinoblastoma: Outcomes following intra-arterial chemotherapy/ophthalmic artery chemosurgery

    Megan A. Rowlands; Ijah Mondesire-Crump; Ariana Levin et al.

    PLOS ONE, Vol. 13 No. 4 · 2018 · English · PLOS Scopus

    Purpose: To report on the rate and timing of retinal reattachment and outcomes for retinoblastoma children who have total retinal detachments at presentation to our center and were treated with intra-arterial chemotherapy (ophthalmic artery chemosurgery, OAC). Patients and methods: Single-center…